SREBF1 and non-small cell lung carcinoma: The results obtained in this study should be tested in future studies with larger or multicenter cohorts of patients with more diverse clinicopathological characteristics and clinical outcomes to further evaluate the potential of SREBP-1 as a prognostic marker in NSCLC.